IDEX CORP /DE/ — Form 8-K
Filed October 28, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
IDEX posted Q3 2026 record net sales of $951.7M (up 8% YoY) and adjusted diluted EPS of $2.33 (up 15% YoY). The company raised full-year organic sales guidance to 6.5–6.8% (from 5–6%) and full-year adjusted diluted EPS guidance to $8.91–$8.96 (from $8.70–$8.85), implying ~12% YoY growth at midpoint. Key drivers: HST segment organic sales +13% (AI data center and semiconductor strength); strong orders of $991M (+13%); margin expansion of 60–70 bps. Capital returns: $129M via dividends and repurchases YTD. Amended $800M revolver extended to September 2031.
Why this rating
Solid operational beat and raised guidance signal momentum; Q3 organic growth 8% and margin expansion modest but real. At ~$13.2B market cap, a $73M sales beat (0.8% of annual run-rate) and ~12% EPS growth guidance lift are meaningful but not transformational. No major M&A, no structural change. Typical mid-cap execution story.
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.